biotech news today glp-1 Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating What Is GLP-1? The Science

fasting or during common illnesses such as acute gastroenteritis.[3] These attacks are associated with hepatomegaly, nonketotic or hypoketotic hypoglycemia, lactic acidosis, hyperammonemia, and elevated hepatic enzymes (alanine aminotransferases and aspartate aminotransferases).[3] Hyperammonemia occurs due to reduced expression of enzymes involved in the urea cycle and noted during acute metabolic decompensation.[6] The remaining half of the affected individuals present during childhood, between 2 and 4 years, with myopathic symptoms such as hypotonia, skeletal muscle weakness, exercise intolerance, episodes of rhabdomyolysis and myoglobinuria and elevated creatine kinase (CK).[3] Additionally, cardiac manifestations like dilated cardiomyopathy may occur and, if not promptly treated with carnitine may progress to heart failure and death

Nutrients, 12 (11), 3304

This interaction underscores the importance of a detailed medical history and open communication with your physician when considering any new supplement or therapy

The peptide blocks formation of reactive oxygen species, detoxifies toxic lipid peroxidation products, and prevents release of tissue-damaging free iron following injuryall critical for limiting oxidative damage during ischemic events